{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:42:14Z","timestamp":1793047334271,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.metabol.2010.08.005","type":"journal-article","created":{"date-parts":[[2010,9,22]],"date-time":"2010-09-22T04:33:09Z","timestamp":1285129989000},"page":"860-866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Serum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men"],"prefix":"10.1016","volume":"60","author":[{"given":"Seungho","family":"Ryu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoosoo","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Geun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliseo","family":"Guallar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2010.08.005_bb0005","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2010.08.005_bb0010","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/01.mol.0000174153.53683.f2","article-title":"Nonalcoholic fatty liver disease and the metabolic syndrome","volume":"16","author":"Marchesini","year":"2005","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.metabol.2010.08.005_bb0015","first-page":"572","article-title":"Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies","volume":"6","author":"Fan","year":"2007","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.metabol.2010.08.005_bb0020","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/j.1440-1746.2007.04995.x","article-title":"Fatty liver now, diabetes and heart attack later? The liver as a barometer of metabolic health","volume":"22","author":"Chitturi","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2010.08.005_bb0025","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.atherosclerosis.2006.08.021","article-title":"Non-alcoholic fatty liver disease and increased risk of cardiovascular disease","volume":"191","author":"Targher","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2010.08.005_bb0030","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","article-title":"Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey","volume":"283","author":"Fang","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2010.08.005_bb0035","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2010.08.005_bb0040","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.metabol.2008.01.030","article-title":"Uric acid and the development of metabolic syndrome in women and men","volume":"57","author":"Sui","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2010.08.005_bb0045","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.amjmed.2006.06.040","article-title":"Prevalence of the metabolic syndrome in individuals with hyperuricemia","volume":"120","author":"Choi","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.metabol.2010.08.005_bb0050","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/HJH.0b013e32832d1f9e","article-title":"Metabolic syndrome, insulin resistance and oxidative stress: adding insights to improve cardiovascular prevention","volume":"27","author":"Amiri","year":"2009","journal-title":"J Hypertens"},{"key":"10.1016\/j.metabol.2010.08.005_bb0055","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/ncpneph0019","article-title":"Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome","volume":"1","author":"Nakagawa","year":"2005","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.metabol.2010.08.005_bb0060","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/aje\/kwg260","article-title":"Risk factors for progression to incident hyperinsulinemia: the Atherosclerosis Risk in Communities Study, 1987-1998","volume":"158","author":"Carnethon","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.metabol.2010.08.005_bb0065","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/01.HYP.0000091371.53502.D3","article-title":"Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation","volume":"42","author":"Masuo","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2010.08.005_bb0070","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2337\/dc07-1276","article-title":"High serum uric acid as a novel risk factor for type 2 diabetes","volume":"31","author":"Dehghan","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2010.08.005_bb0075","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1210\/er.2008-0033","article-title":"Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes?","volume":"30","author":"Johnson","year":"2009","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2010.08.005_bb0080","doi-asserted-by":"crossref","first-page":"C584","DOI":"10.1152\/ajpcell.00600.2006","article-title":"Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative\/nitrosative stress","volume":"293","author":"Sautin","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.metabol.2010.08.005_bb0085","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.molmed.2006.10.001","article-title":"Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease","volume":"12","author":"Videla","year":"2006","journal-title":"Trends Mol Med"},{"issue":"Suppl 2","key":"10.1016\/j.metabol.2010.08.005_bb0090","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2036.2005.02601.x","article-title":"Review article: role of oxidative stress in the progression of non-alcoholic steatosis","volume":"22","author":"Albano","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.metabol.2010.08.005_bb0095","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S1590-8658(02)80194-3","article-title":"Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study","volume":"34","author":"Lonardo","year":"2002","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.metabol.2010.08.005_bb0100","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jhep.2008.11.021","article-title":"Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study","volume":"50","author":"Li","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2010.08.005_bb0105","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1080\/00365520500319591","article-title":"Obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease: a cross-sectional case-control study","volume":"41","author":"Lee","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.metabol.2010.08.005_bb0110","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1291\/hypres.30.823","article-title":"Fatty liver and uric acid levels predict incident coronary heart disease but not stroke among atomic bomb survivors in Nagasaki","volume":"30","author":"Baba","year":"2007","journal-title":"Hypertens Res"},{"key":"10.1016\/j.metabol.2010.08.005_bb0115","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/gast.2003.50032","article-title":"Defining nonalcoholic fatty liver disease: implications for epidemiologic studies","volume":"124","author":"Clark","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2010.08.005_bb0120","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1053\/gast.2002.36572","article-title":"AGA technical review on nonalcoholic fatty liver disease","volume":"123","author":"Sanyal","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2010.08.005_bb0125","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1373\/clinchem.2006.081257","article-title":"Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease","volume":"53","author":"Chang","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2010.08.005_bb0130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1373\/clinchem.2006.078980","article-title":"gamma-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men","volume":"53","author":"Ryu","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2010.08.005_bb0135","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","article-title":"Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference","volume":"37","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2010.08.005_bb0140","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1590-8658(02)80111-6","article-title":"Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild\/moderate abnormalities of liver transaminases","volume":"34","author":"Mathiesen","year":"2002","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.metabol.2010.08.005_bb0145","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2010.08.005_bb0150","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1017\/S1368980008002802","article-title":"Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians","volume":"12","author":"Wen","year":"2009","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.metabol.2010.08.005_bb0155","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/j.1523-1755.2005.00273.x","article-title":"Hyperuricemia induces endothelial dysfunction","volume":"67","author":"Khosla","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.metabol.2010.08.005_bb0160","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/hep.23717","article-title":"Association between serum uric acid level and chronic liver disease in the United States","volume":"52","author":"Afzali","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2010.08.005_bb0165","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1681\/ASN.2008010080","article-title":"Elevated uric acid increases the risk for kidney disease","volume":"19","author":"Obermayr","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2010.08.005_bb0170","doi-asserted-by":"crossref","first-page":"R116","DOI":"10.1186\/ar2775","article-title":"Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis","volume":"11","author":"Daoussis","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.metabol.2010.08.005_bb0175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.ajkd.2005.10.006","article-title":"Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level","volume":"47","author":"Siu","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.metabol.2010.08.005_bb0180","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/j.1550-8528.1997.tb00278.x","article-title":"Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist\/hip ratio and other anthropometric measurements in Mexican Americans\u2014a 7-year prospective study","volume":"5","author":"Wei","year":"1997","journal-title":"Obes Res"},{"key":"10.1016\/j.metabol.2010.08.005_bb0185","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/oby.2001.94","article-title":"Sensitivity and specificity of anthropometrics for the prediction of diabetes in a biracial cohort","volume":"9","author":"Stevens","year":"2001","journal-title":"Obes Res"},{"key":"10.1016\/j.metabol.2010.08.005_bb0190","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/bmj.1.6164.653","article-title":"Hyperuricaemia in hypertension: role of alcohol","volume":"1","author":"Ramsay","year":"1979","journal-title":"Br Med J"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049510002878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049510002878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:52:56Z","timestamp":1758426776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049510002878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0026049510002878"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2010.08.005","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2010.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}